Stocks & Investing
Thu, September 19, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 8, 2024
Thu, May 18, 2023
[ 12:00 AM ] - WOPRAI
Mon, April 24, 2023
[ 12:00 AM ] - WOPRAI
Tue, March 7, 2023
[ 12:00 AM ] - WOPRAI
Fri, November 11, 2022
[ 12:00 AM ] - WOPRAI
Fri, August 12, 2022
Fri, July 1, 2022
[ 12:00 AM ] - WOPRAI
Wed, June 1, 2022
[ 12:00 AM ] - WOPRAI
Fri, April 1, 2022
[ 12:00 AM ] - WOPRAI
Tue, November 9, 2021
[ 12:00 AM ] - WOPRAI
Fri, October 22, 2021
[ 12:00 AM ] - WOPRAI
Fri, July 23, 2021
Fri, January 15, 2021
Mon, September 14, 2015
Wed, October 29, 2014
[ 12:00 AM ] - WOPRAI
Tue, October 28, 2014 Emmanuel Papadakis Maintained (BNTX) at Strong Buy with Increased Target to $150 on, Sep 19th, 2024
Emmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Strong Buy with Increased Target from $95 to $150 on, Sep 19th, 2024.
Emmanuel has made no other calls on BNTX in the last 4 months.
There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 3 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Eliana Merle of "UBS" Maintained at Hold with Increased Target to $131 on, Wednesday, September 18th, 2024
- Jessica Fye of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $125 on, Monday, September 16th, 2024
- Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024
These are the ratings of the 3 analyists that currently disagree with Emmanuel
- Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $150 on, Tuesday, September 17th, 2024
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $113 on, Monday, September 16th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $150 on, Monday, September 16th, 2024
